131 related articles for article (PubMed ID: 19451213)
1. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.
Yasui T; Saijo A; Uemura H; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
Eur J Endocrinol; 2009 Aug; 161(2):267-73. PubMed ID: 19451213
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 is associated with monocyte chemoattractant protein-1 and soluble E-selectin levels in peripheral blood of newly post-menopausal women.
Yasui T; Saijo A; Uemura H; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Reprod Immunol; 2009 Jul; 81(1):97-102. PubMed ID: 19501916
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene reduces circulating levels of interleukin-7 and monocyte chemoattractant protein-1 in postmenopausal women.
Yasui T; Uemura H; Hyodo S; Yamada M; Yamamoto S; Maegawa M; Tsuchiya N; Noguchi M; Yuzurihara M; Kase Y; Irahara M
Atherosclerosis; 2009 Jun; 204(2):471-5. PubMed ID: 18976766
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
6. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
8. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women.
Sumino H; Ichikawa S; Ohyama Y; Takahashi T; Saito Y; Nakamura T; Kanda T; Kurabayashi M
Am J Cardiol; 2005 Jul; 96(1):148-53. PubMed ID: 15979455
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
[TBL] [Abstract][Full Text] [Related]
10. Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist.
Matsui S; Yasui T; Uemura H; Yamamoto S; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Reprod Immunol; 2011 Aug; 90(2):227-34. PubMed ID: 21726903
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.
Shifren JL; Rifai N; Desindes S; McIlwain M; Doros G; Mazer NA
J Clin Endocrinol Metab; 2008 May; 93(5):1702-10. PubMed ID: 18303079
[TBL] [Abstract][Full Text] [Related]
12. [Changes in serum levels of C-reactive protein and the soluble adhesion molecules, sE-selectin and sICAM-1, after transdermal 17-beta estradiol replacement].
Kvasnicka J; Zivný J
Ceska Gynekol; 2001 May; 66(3):161-5. PubMed ID: 11464371
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women.
Vongpatanasin W; Tuncel M; Wang Z; Arbique D; Mehrad B; Jialal I
J Am Coll Cardiol; 2003 Apr; 41(8):1358-63. PubMed ID: 12706932
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy.
Ruszkowska B; Sokup A; Kulwas A; Kwapisz J; Góralczyk K; Socha MW; Rhone P; Rość D
Acta Obstet Gynecol Scand; 2013 Jul; 92(7):841-6. PubMed ID: 23472599
[TBL] [Abstract][Full Text] [Related]
15. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
[TBL] [Abstract][Full Text] [Related]
16. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
[TBL] [Abstract][Full Text] [Related]
17. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H
Menopause; 2007; 14(6):978-84. PubMed ID: 17595593
[TBL] [Abstract][Full Text] [Related]
18. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women.
Farzati A; Esposito K; Colacurci N; Fornaro F; Chiantera V; Farzati B
Fertil Steril; 2002 Mar; 77(3):476-80. PubMed ID: 11872198
[TBL] [Abstract][Full Text] [Related]
19. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
Zanger D; Yang BK; Ardans J; Waclawiw MA; Csako G; Wahl LM; Cannon RO
J Am Coll Cardiol; 2000 Nov; 36(6):1797-802. PubMed ID: 11092646
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women.
Xia X; Zhang S; Yu Y; Zhao N; Liu R; Liu K; Chen X
J Reprod Immunol; 2009 Jul; 81(1):89-96. PubMed ID: 19497624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]